Quick Answer : documents required for third party pharma manufacturing
You need three documents before any WHO-GMP manufacturer will touch your order: a Wholesale Drug Licence, a GST registration, and a signed manufacturing agreement. Everything else trademark, formula sheet, packaging artwork, FSSAI licence if you’re doing supplements can be arranged in parallel while your first batch is in production. The drug licence is the bottleneck. It takes 30–45 days because an inspector has to physically check your premises, so apply for it the day you decide to start, not after you’ve picked your products.
Most people researching third-party pharma manufacturing in India start with the product list which molecules, which dosage forms, which packaging. That’s backwards. The manufacturer can’t legally accept your order without paperwork proving you’re allowed to trade medicines at all. CDSCO and the state drug control authorities treat this as non-negotiable, and a WHO-GMP or Schedule M compliant facility won’t risk its own licence by working with an unregistered brand.
Here’s every document you actually need, why it exists, and roughly how long each one takes.
1. Business Identity Documents
Before a factory discusses formulations with you, it needs to know who you legally are.
Certificate of Incorporation or Registration
proof of your business structure (proprietorship, partnership, LLP, or private limited company). A manufacturer’s compliance team will ask for this before opening a file on you.
Company PAN Card
your tax identity. Required for GST linkage and for the manufacturing agreement itself.
Director/Partner ID and Address Proof
Aadhaar and PAN of everyone with legal authority to sign on the company’s behalf.
Company Profile
not legally mandatory, but every serious manufacturer asks for a one-page profile covering your business history, target therapeutic segments, and expected order volumes. It speeds up onboarding because the manufacturer isn’t starting from zero.
MSME/Udyam Registration
optional, but useful. Some manufacturers offer better commercial terms to MSME-registered brands, and it helps with certain government tenders later.
2. Wholesale Drug Licence the One That Can’t Be Skipped
This is the document that actually gates everything else. Under the Drugs and Cosmetics Act, no one can trade, store, or distribute pharmaceutical formulations in India without a valid drug licence issued by the State Drug Control Authority or CDSCO.
Two things trip up first-time applicants: you need a minimum of 15 square metres of storage space that meets drug-storage conditions, and you need a registered pharmacist attached to the licence for technical supervision even if you’re not manufacturing in-house yourself. Inspectors verify both in person, which is why this licence takes 30–45 days rather than the week or two people expect.
Your third-party manufacturing partner will not process your first purchase order without a copy of this licence. There’s no workaround here, and no manufacturer with a real WHO-GMP certification will offer one.
3. GST Registration Certificate
You need a GSTIN to legally bill and be billed by your manufacturer, and to move stock across state lines. Registration itself is quick five to seven days through the GST portal and costs almost nothing if you file it yourself. Most general formulations attract 5% GST; several life-saving drug categories are fully exempt, which matters when you’re pricing your first batch.
Keep monthly GST filing current from day one. A lapsed GSTIN mid-production is a common reason batches get held up at the packaging stage.
4. Trademark Certificate or NOC
Brand names in pharma get copied fast a generic cough syrup name can be live on three other labels within months if it isn’t protected. You have two options here, not one:
- Trademark registration gives you enforceable legal ownership of the name and logo, but the process runs 18–24 months in India.
- NOC (No Objection Certificate) is a signed letter confirming you’re the rightful owner of the brand name while the trademark application is still pending. This is what actually lets the manufacturer print your name on cartons in the meantime.
Practical approach: file the trademark application immediately, then use the filing receipt plus an NOC to start production without waiting two years.
5. The Manufacturing Agreement and What Should Actually Be Inside It
This is the contract that protects both sides, and it’s worth more scrutiny than most new brand owners give it. A properly drafted agreement covers:
- Per-batch pricing and minimum order quantity
- Delivery timelines and lead times
- Raw material sourcing and quality-check criteria
- A quality agreement clause defining testing standards and who’s accountable if a batch fails spec
- An NDA (Non-Disclosure Agreement) so your formula doesn’t end up with a competitor
- A change-control clause how formula or process changes get approved and documented after production starts
Brands that skip the quality agreement and change-control terms are the ones who end up in disputes six months later when a batch doesn’t match what was promised. If your manufacturer’s draft agreement doesn’t mention these, ask for them explicitly a reputable third-party pharma manufacturer with proper documentation practices will already have templates for this.
6. Formula Sheet and Master Batch Record (MBR)
The Formula Sheet (or Master Formula Record) lists exact ingredients, quantities, and dosage form a 500mg tablet, a 100ml syrup bottle, whatever your product is. This is what the manufacturer’s R&D and production teams actually work from.
Once production begins, the manufacturer generates a Master Batch Record for each run a detailed log of what was made, when, with which raw material lots, and under what conditions. You don’t create this yourself, but you should ask to see it, because it’s your evidence trail if a regulatory question ever comes up about a specific batch.
7. Packaging Artwork and Labelling Compliance
Design, colour scheme, and every line of text on your strips, bottles, and cartons has to follow drug-labelling rules set by the regulatory authority batch number, manufacturing date, expiry, MRP, composition, and manufacturer details all have mandated placement and formatting. This is usually the last document finalised before the first batch runs, and manufacturers typically turn it around in three to seven days once you approve the design.
8. FSSAI Licence (If You’re Doing Supplements, Not Drugs)
If part of your range is a nutraceutical, vitamin, or dietary supplement rather than a scheduled drug, you need a separate FSSAI licence a drug licence alone doesn’t cover food-category products. This is a common gap for brands entering both categories at once, and missing it stalls only the supplement SKUs while your drug products move ahead fine.
9. Insurance Certificate
Not always demanded upfront, but increasingly standard practice: product liability insurance covering both the brand owner and the manufacturer against claims arising from a defective batch. Larger manufacturers often require proof of this before signing off on bigger order volumes.
Documents at a Glance
How Long Each Document Actually Takes
Why This Paperwork Actually Matters — Beyond Compliance
It keeps regulators off your back. CDSCO and state drug inspectors can visit a manufacturing site without notice. Incomplete documentation on either side yours or the manufacturer’s can halt a production run mid-batch.
It protects patients, not just your business. If a batch has a quality issue, proper batch records let the manufacturer trace and recall exactly the affected stock within hours instead of pulling every product off shelves.
It prevents disputes that cost more than the paperwork ever would. Most conflicts between brand owners and manufacturers trace back to something that was never put in writing an assumed timeline, an unstated quality standard, a formula change nobody documented.
Mistakes New Pharma Brands Make With Documentation
- Waiting until the product list is final to apply for the drug licence. The licence isn’t product-specific at the application stage start it the moment you decide to launch.
- Treating the manufacturing agreement as a formality. Skipping the quality and change-control clauses is the single most common cause of later disputes.
- Assuming a pending trademark application is enough long-term. It gets you started, but without an NOC and eventual registration, you have no real legal protection against copycats.
- Forgetting FSSAI for supplement lines. Brands launching a mixed drug-and-supplement range often miss this until their supplement SKUs get stuck.
Frequently Asked Questions
Q1. Can I start third-party pharma manufacturing without a wholesale drug licence?
Ans. No. It’s a legal requirement, not a formality no compliant manufacturer will produce or ship without seeing a valid copy.
Q2. How long does it take to get a drug licence and GST number together?
Ans. GST usually comes through in about a week if filed online. The drug licence takes longer 30 to 45 days because it requires a physical site inspection.
Q3. Is a trademark certificate mandatory before I start production?
Ans. No. You can begin with a filed application and an NOC. Full registration (18–24 months) can run in parallel while you’re already selling.
Q4. What does the NDA in a manufacturing agreement actually cover?
Ans. It legally prevents the manufacturer from sharing your formula, packaging design, or business terms with any other client including competing brands they may also work with.
Q5. Do I need a separate licence for supplements or nutraceuticals?
Ans. Yes. If the product falls under food/supplement category rather than a scheduled drug, you’ll need an FSSAI licence in addition to (not instead of) your drug licence for the pharmaceutical SKUs.
Q6. What happens if my manufacturing agreement doesn’t include a quality agreement clause?
Ans. You have no contractual basis to hold the manufacturer accountable if a batch fails testing or doesn’t match agreed specifications. Always ask for this to be added explicitly before signing.
This guide reflects documentation requirements under the Drugs and Cosmetics Act, CDSCO guidelines, and GST regulations as applicable in 2026. Requirements can vary slightly by state confirm specifics with your state drug control authority before applying.
About the Author
Reviewed by the Regulatory & Compliance Team, JM Laboratories a WHO-GMP and ISO-certified third-party pharma manufacturer based in Chandigarh, operating since 2006. The team works directly with new pharma brands on documentation, licensing, and production onboarding, and has guided hundreds of first-time brand owners through the exact process covered in this guide.